Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 784 | 199 | 839 | 292 | 273 |
| Gross Profit | 784 | 199 | 839 | 292 | 273 |
| Operating Expenses | 104,922 | 71,932 | 106,348 | 60,245 | 83,475 |
| Operating Income | -104,137 | -71,733 | -105,508 | -59,953 | -83,202 |
| Interest Expense | 314 | 314 | 480 | 476 | 467 |
| Other Income | -4,047 | -4,862 | -959 | 261 | 1,529 |
| Pre-tax Income | -108,497 | -76,909 | -106,948 | -60,169 | -82,140 |
| Income Tax | N/A | 2,165 | N/A | N/A | N/A |
| Net Income Continuous | -108,497 | -79,074 | -107,382 | -60,169 | -82,140 |
| Net Income | $-108,497 | $-79,074 | $-107,382 | $-60,169 | $-82,140 |
| EPS Basic Total Ops | -5.52 | -4.32 | -6.05 | -3.48 | -4.68 |
| EPS Basic Continuous Ops | -5.54 | -4.34 | -6.11 | -3.43 | -4.71 |
| EPS Diluted Total Ops | -5.52 | -4.32 | -6.05 | -3.48 | -4.68 |
| EPS Diluted Continuous Ops | -5.54 | -4.34 | -6.11 | -3.43 | -4.71 |
| EBITDA(a) | $-102,926 | $-70,232 | $-103,647 | $-57,647 | $-82,081 |